Skip to main content

Year: 2026

Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026

LONDON and GAITHERSBURG, Md., May 21, 2026 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, announces the online publication of an abstract submitted to the American Society of Clinical Oncology (ASCO) Annual Meeting, to be held May 29 – June 2, 2026, in Chicago, Illinois. “Data to be presented at the upcoming ASCO Annual Meeting provides insight into the use of obe-cel in patients with B-ALL and extramedullary disease (EMD), which is typically associated with shorter median and long-term survival compared to marrow-only relapse. With an overall response rate of 59% and a median duration of response (mDOR) of 42.6 months for patients with EMD, obe-cel may be considered as a...

Continue reading

Abcourt announces its financial results for the quarter ended March 31, 2026

ROUYN-NORANDA, Quebec, May 21, 2026 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB : ABMBF) announces its financial results for the third quarter ended March 31, 2026. All monetary values ​in this press release are expressed in Canadian dollars, unless otherwise indicated. Financial statements and management discussion and analysis are available on SEDAR+. Summary of financial results(In dollars) Three months ended March 31, Nine months ended March 31,  2026   2025   2026   2025  Revenues 7,877,554   –   12,766,703   –  Costs of sales 12,779,778   –   24,457,126   –  Tax credit resources (1,032,250 ) –   (3,288,901 ) –  Loss from mining operations (3,869,974 ) –   (8,401,522 ) –  Administration expenses 1,469,001   1,068,917   3,646,730   2,499,582  Care...

Continue reading

Banqup delivers 40,3% y/y growth in subscription revenue in Q1 2026

La Hulpe, Belgium – 21 May 2025, 22:30 CEST – REGULATED INFORMATION – Banqup Group SA, (Euronext: BANQ) (Banqup, Company), a leading provider of integrated financial workflow management solutions, publishes its business update for the first quarter of 2026.  Key HighlightsSolid Group revenue1,2 growth of 5,0% y/y from € 12,5m in Q1 2025 to € 13,1m in Q1 2026. This was primarily driven by strong growth momentum in digital revenue1 (+14,4% y/y). Banqup’s ARR Digital Services Revenue increased by 12,7% y/y, reaching € 47,0m at the end of March 2026. Completed divestment of Baltic Activities to Fitek Oü on 16 March 2026, aligning with Banqup’s strategy to streamline its operations into a pure-play SaaS company. Including proceeds from the sale, liquidity as of 31 March 2026 stands at € 8,6m. Launched Value Creation Plan to drive cost optimisations...

Continue reading

OFA Group Transitions to U.S. Domestic Issuer Status; Reaffirms United States as the Center of Its Growth Strategy

Torrance, California, May 21, 2026 (GLOBE NEWSWIRE) — OFA Group (NASDAQ: OFAL) (“OFA Group” or the “Company”) today announced that, effective April 1, 2026, the Company ceased to qualify as a “foreign private issuer” within the meaning of Rule 405 under the Securities Act of 1933 and Rule 3b-4 under the Securities Exchange Act of 1934, and now reports as a U.S. domestic issuer under the Securities and Exchange Commission’s rules applicable to domestic registrants. The transition reflects the Company’s evolution over the past year and the geographic concentration of its shareholders, leadership, operations, and revenue in the United States. While OFA Group remains incorporated in the Cayman Islands and maintains a subsidiary in Hong Kong, the Company’s principal executive offices,...

Continue reading

Announcement from Eimskip: Agreement between SA (on behalf of Eimskip) and the Seafarers Union of Iceland (on behalf of harbor employees)

The Confederation of Icelandic Enterprise (SA), on behalf of Eimskip, and the Seafarer’s Union of Iceland (SÍ) have entered into an agreement concerning harbor employees at Sundahöfn. The strike previously announced by SÍ, which was scheduled to commence on 26 May 2026, has been withdrawn. Under the agreement, negotiations on a collective wage agreement will be deferred until 31 October 2026 while a competency analysis of port operations is carried out. Embargo on strikes will apply during this period. In parallel, work has commenced on the implementation of a formal competency-based pay system for harbor employees. The system will be based on an objective job evaluation framework, whereby employee competence, skills and responsibilities form the basis for more efficient wage setting and clearer salary progression. The Education and Training...

Continue reading

Genco Shipping & Trading Limited Files Investor Presentation and Urges Shareholders to Vote for the Company’s Highly Qualified Nominees and Reject Diana’s Inadequate Tender Offer

Highlights Genco’s Proven Comprehensive Value Strategy Delivering Superior Returns and Significant Momentum Underway to Capture Upside Diana’s Offer Remains Inadequate and its Handpicked Director Nominees Pose Significant Risks to Genco Shareholders’ Investment Genco Urges Shareholders to Vote “FOR” the Re-Election of Genco’s Nominees on the WHITE Proxy Card Today – and “WITHHOLD” on Diana’s Nominees Reminds Shareholders Not to Tender Their Shares into Diana’s Tender Offer Presentation and Information on How to Vote Available at www.GencoDrivesSuperiorReturns.com NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today posted an investor presentation in connection...

Continue reading

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

SEATTLE, May 21, 2026 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the following investor conferences.Craig-Hallum 23rd Annual Institutional Investor Conference – Minneapolis, MNHosting 1×1 meetings on Thursday, May 28th William Blair 46th Annual Growth Stock Conference – Chicago, ILPresentation on Wednesday, June 3rd at 3:20 p.m. Central TimeInterested parties may access a live and archived webcast of the presentation from the William Blair Growth Stock Conference on the “Investors” section of the company website at: www.adaptivebiotech.com. About Adaptive Biotechnologies Adaptive Biotechnologies...

Continue reading

Americold Realty Trust, Inc. Declares Second Quarter 2026 Dividend

ATLANTA, May 21, 2026 (GLOBE NEWSWIRE) — Americold Realty Trust (NYSE: COLD), a global leader in temperature-controlled logistics, real estate, and value-added services focused on the ownership, operation, acquisition and development of temperature-controlled warehouses, today announced that its Board of Directors has declared a dividend of $0.23 per share for the second quarter of 2026, payable to holders of the Company’s common stock. The dividend will be payable in cash on July 15, 2026 to stockholders of record at the close of business on June 30, 2026. About Americold Realty Trust, Inc. Americold (NYSE: COLD) is a global leader in temperature-controlled logistics and real estate, with a more than 120-year legacy of innovation and reliability. With more than 220 facilities across North America, Europe, Asia-Pacific, and South...

Continue reading

Cavco Industries Reports Fiscal 2026 Fourth Quarter and Year End Results

Cavco finishes fiscal year with record number of homes sold PHOENIX, May 21, 2026 (GLOBE NEWSWIRE) — Cavco Industries, Inc. (Nasdaq: CVCO) today announced financial results for the fourth quarter and fiscal year ended March 28, 2026. Quarterly HighlightsNet revenue of $550 million up 8% from $508 million in the prior year quarter. Gross profit as a percentage of Net revenue was 23.1%, up 30 basis points (“bps”), with factory-built housing Gross profit as a percentage of Net revenue at 21.2%, down 110 bps. Net income was $42 million. Net income per diluted share was $5.42 compared to $4.47.Full Fiscal Year HighlightsNet revenue was $2,245 million, up $230 million or 11.4% compared to $2,015 million last year. Factory-built housing Gross profit as a percentage of Net revenue was 22.1%, compared to 22.9%. Income...

Continue reading

Zoom Communications Reports Financial Results for the First Quarter of Fiscal Year 2027

First quarter total revenue of $1,239.0 million, up 5.5% year over year as reported and 4.6% in constant currency First quarter Enterprise revenue of $755.7 million, up 7.2% year over year Trailing 12-month net dollar expansion rate for Enterprise customers increased to 99% from 98% as of the same quarter last fiscal year First quarter GAAP operating margin of 25.1%, up 450 bps year over year, and non-GAAP operating margin of 41.1%, up 130 bps year over year Increased total common stock repurchase authorization by $1.0 billion, incremental to the $625.0 million remaining authorization as of April 30, 2026SAN JOSE, Calif., May 21, 2026 (GLOBE NEWSWIRE) — Zoom Communications, Inc. (NASDAQ: ZM), today announced financial results for the first fiscal quarter ended April 30, 2026. “We saw continued momentum in the first quarter,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.